Objective: Self-expandable metallic stents are superior to establish and preserve biliary drainage in malignant biliary obstructions. Endobiliary radiofrequency ablation (EB-RFA) is an important adjunct to increase the efficacy and length of the stent patency. This study is on the efficacy and safety of transhepatic EB-RFA and discusses its procedural steps and technical tips for successful implementation. Material and Methods: Clinical and imaging data of eight patients were retrospectively analyzed. The intervention included EBRFA, stenting, balloon dilatation and temporary internal biliary catheterization of previously untreated cases. The technical efficacy was determined as the percentage of successfully catheterized patients. The short-term clinical efficacy was determined as the comparison of pre- and post-procedural total and direct bilirubin levels. Results: The mean pre-ablation luminal diameter was 2.4±0.7 mm and the mean post-ablation luminal diameter 7.8±2.0 mm. No intraprocedural and 30-day mortality was encountered. Multiple hepatic abscesses developed in a patient who had re-ablation and two others experienced cholangitis. The most common minor complication was abdominal pain. The preprocedural total bilirubin level was 8.39±3.45 and the direct bilirubin level was 6.82±3.11. The postprocedural total bilirubin level at 7th day was 4.10±2.85 and direct bilirubin level was 2.96±2.16. Patients were followed up to 6.5 months after the procedure. The mean patency time was 56 days and the mean survival was 122 days. Conclusion: This study supports previous reports on EB-RFA and shows the safety and the efficacy of the technique and its implementation. Keeping all procedural steps and possible complications in mind, it has a relatively short learning curve.
Keywords: Endobiliary radiofrequency ablation; malign biliary obstruction; stent; impedance
Amaç: Malign safra yolu darlıklarında, kendi kendine genişleyen metalik stentler biliyer drenajın sağlanmasında ve korunmasında kullanılmaktadır. Endobiliyer radyofrekans ablasyon (EB-RFA) stent açıklığının sağlanmasında ve patens süresinin uzatılmasında önemli bir yardımcıdır. Çalışmanın amacı, transhepatik EB-RFA'nın etkinliği ve güvenliğini göstermek, başarılı uygulama için prosedür adımlarını ve teknik ipuçlarını paylaşmaktır. Gereç ve Yöntemler: Maligniteye bağlı biliyer darlığı bulunan 8 hasta retrospektif olarak incelendi. İşlem basamakları; EB-RFA, stentleme, balon dilatasyon ve daha önce tedavi edilmemiş olguların geçici internal safra kateterizasyonunu içermektedir. Teknik etkinlik, başarılı bir şekilde kateterize edilmiş hastaların yüzdesi olarak belirlendi. Kısa süreli klinik etkinlik ise işlem öncesi ve sonrası total ve direkt bilurubin değerlerinin karşılaştırılmasıyla değerlendirildi. Bulgular: Ablasyon öncesi ortalama lümen çapı 2,4±0,7 mm ve ablasyon sonrası ortalama lümen çapı 7,8±2,0 mm idi. Prosedür sırasında ve sonrasındaki 30 günde mortalite izlenmedi. İki hastada işleme bağlı kolanjit gelişti ve birinde 2. ablasyon sonrası çok sayıda hepatik apse izlendi. İşlem öncesi total bilurubin düzeyi 8,39±3,45 ve direkt bilurubin düzeyi 6,82±3,11 idi. İşlem sonrası 7. günde ise sırasıyla 4,10±2,85 ve 2,96±2,16 olarak ölçüldü. Hastalar işlemden sonra 6,5 aya kadar takip edildi. Ortalama stent patensi 56 gün ve ortalama sağkalım 122 gündü. Sonuç: Bu çalışma, literatürdeki diğer EB-RFA çalışmalarını destekler nitelikte olup, tekniğin ve uygulamasının güvenilir ve etkili olduğunu göstermektedir. Tüm prosedür adımlarını ve olası komplikasyonları göz önünde bulundurarak nispeten kısa bir öğrenme eğrisine sahiptir.
Anahtar Kelimeler: Endobiliyer radyofrekans ablasyon; malign biliyer darlık; stent; empedans
- Singh A, Siddiqui UD. The role of endoscopy in the diagnosis and management of cholangiocarcinoma. J Clin Gastroenterol. 2015;49(9):725-37. [Crossref] [PubMed]
- McKinley SK, Chawla A, Ferrone CR. Inoperable biliary tract and primary liver tumors: palliative treatment options. Surg Oncol Clin N Am. 2019;28(4):745-62. [Crossref] [PubMed]
- Sawas T, Al Halabi S, Parsi MA, Vargo JJ. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc. 2015;82(2):256-67.e7. [Crossref] [PubMed]
- Loew BJ, Howell DA, Sanders MK, Desilets DJ, Kortan PP, May GR, et al. Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc. 2009;70(3):445-53. [Crossref] [PubMed]
- Pai M, Valek V, Tomas A, Doros A, Quaretti P, Golfieri R, et al.*Mosconi C, Habib N. Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol. 2014 Feb;37(1):235-40. Epub 2013 Jul 11. [Crossref] [PubMed]
- Wang J, Zhao L, Zhou C, Gao K, Huang Q, Wei B, et al. Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for nonresectable malignant biliary obstruction ımproves stent patency but not survival. Medicine (Baltimore). 2016;95(15):e3329. [Crossref] [PubMed] [PMC]
- Steel AW, Postgate AJ, Khorsandi S, Nicholls J, Jiao L, Vlavianos P, et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc. 2011;73(1):149-53. [Crossref] [PubMed]
- Figueroa-Barojas P, Bakhru MR, Habib NA, Ellen K, Millman J, Jamal-Kabani A, et al. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. J Oncol. 2013;2013:910897. [Crossref] [PubMed] [PMC]
- Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;19-26;340(8834-8835):1488-92. [Crossref] [PubMed]
- Cho NJ, Lee TH, Park SH, Lee HM, Hyun KH, Lee SH, et al. Endoscopic removal of a proximally migrated metal stent during balloon sweeping after stent trimming. Clin Endosc. 2013;46(4):418-22. [Crossref] [PubMed] [PMC]
- Familiari P, Bulajic M, Mutignani M, Lee LS, Spera G, Spada C, et al. Endoscopic removal of malfunctioning biliary self-expandable metallic stents. Gastrointest Endosc. 2005;62(6):903-10. [Crossref] [PubMed]
- Li TF, Huang GH, Li Z, Hao CF, Ren JZ, Duan XH, et al. Percutaneous transhepatic cholangiography and intraductal radiofrequency ablation combined with biliary stent placement for malignant biliary obstruction. J Vasc Interv Radiol. 2015;26(5):715-21. [Crossref] [PubMed]
- Laleman W, van der Merwe S, Verbeke L, Vanbeckevoort D, Aerts R, Prenen H, et al. A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study. Endoscopy. 2017;49(10):977-82. [Crossref] [PubMed]
- Khorsandi SE, Zacharoulis D, Vavra P, Navarra G, Kysela P, Habib N. The modern use of radiofrequency energy in surgery, endoscopy and interventional radiology. Eur Surg. 2008;40:204-10. [Crossref]
- Cho JH, Lee KH, Kim JM, Kim YS, Lee DH, Jeong S. Safety and effectiveness of endobiliary radiofrequency ablation according to the different power and target temperature in a swine model. J Gastroenterol Hepatol. 2017;32(2):521-6. [Crossref] [PubMed]
- Dolak W, Schreiber F, Schwaighofer H, Gschwantler M, Plieschnegger W, Ziachehabi A, et al; Austrian Biliary RFA Study Group. Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc. 2014;28(3):854-60. [Crossref] [PubMed]
- Hansen C, Ronot M, Toso C, Rubbia-Brandt L, Boudabbous S, Terraz S. Endobiliary hepatocellular carcinoma: a rare tumor mimicking cholangiocarcinoma. Diagn Interv Imaging. 2016;97(3):365-7. [Crossref] [PubMed]
- Pomerantz BJ. Biliary tract interventions. Tech Vasc Interv Radiol. 2009;12(2):162-70. [Crossref] [PubMed]
- Mizandari M, Pai M, Xi F, Valek V, Tomas A, Quaretti P, et al. Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol. 2013;36(3):814-9. [Crossref] [PubMed]
- Sofi AA, Khan MA, Das A, Sachdev M, Khuder S, Nawras A, et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2018;87(4):944-51.e1. [Crossref] [PubMed]
- Betgeri S, Rajesh S, Arora A, Panda D, Bhadoria AS, Mukund A. Percutaneous endobiliary RFA combined with balloon-sweep for re-opening occluded metallic biliary stents. Minim Invasive Ther Allied Technol. 2017;26(2):124-7. Epub 2016 Sep 27. [Crossref] [PubMed]
.: İşlem Listesi